` 688526 (Wuhan Keqian Biology Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

688526
vs
S
Shanghai Composite

Over the past 12 months, Wuhan Keqian Biology Co Ltd has underperformed Shanghai Composite, delivering a return of +21% compared to the Shanghai Composite's +24% growth.

Stocks Performance
688526 vs Shanghai Composite

Loading
688526
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688526 vs Shanghai Composite

Performance Gap Between 688526 and SSEC
HIDDEN
Show

Performance By Year
688526 vs Shanghai Composite

Loading
688526
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Wuhan Keqian Biology Co Ltd vs Peers

Shanghai Composite
688526
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Wuhan Keqian Biology Co Ltd
Glance View

Market Cap
7.6B CNY
Industry
Pharmaceuticals

Wuhan Keqian Biology Co., Ltd. engages in the research, development, production, and sale of veterinary biological products. The company is headquartered in Wuhan, Hubei and currently employs 848 full-time employees. The company went IPO on 2020-09-22. The firm's main products are vaccines for swine and poultry. The firm mainly conducts its businesses within the China market.

Wuhan Keqian Biology Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top